The Anti-obesity Effects of Xanthohumol are Mediated Partly by
the Adenosine Monophosphate-Protein Kinase Signaling Pathway
Janaiya Samuels, Zachary Fitch, Hong-Gil Chae, Srujana Rayalam, Ph.D
Department of Pharmaceutical Sciences, School of Pharmacy, Philadelphia College of Osteopathic Medicine - GA Campus, Suwanee, GA

Abstract
Xanthohumol (XN), a flavonoid compound extracted from the hop plant
Humulus lupus, has been studied for its anti-cancer and antiadipogenic effects. In this study, we have investigated the effects of XN
on the inhibition of adipogenesis and the induction of browning in 3T3L1 adipocytes. Furthermore, we provide evidence for the first time on
the role of adenosine monophosphate-activated protein kinase (AMPK)
signaling pathway in XN-induced anti-obesity effects. Browning of
white adipose tissue, WAT, is emerging as a novel approach to address
obesity. AMPK is activated in response to stress-like exposure to cold
and has been shown to induce browning of WAT. 3T3-L1 preadipocytes
were differentiated using a cocktail comprised of insulin,
dexamethasone, isobutyl methyl xanthine, and rosiglitazone in DMEM
supplemented with 10% FBS following an 8-10 adipogeneic
differentiation protocol. Mature adipocytes were treated with either
0.01% DMSO or varying doses of XN for 24-48hrs. Treatment of
mature 3T3-L1 adipocytes with XN 6.25µM and 25µM decreased lipid
content during adipogenesis and increased the expression of
uncoupling protein 1 (UCP1), in a dose-dependent manner in mature
adipocytes. XN further increased mitochondrial activity in mature
adipocytes after 24 hours, suggesting browning of adipocytes. To
demonstrate the role of AMPK pathway in XN-induced anti-obesity
effects, mature adipocytes were treated with either 0.01% DMSO or XN
25µM in the presence or absence of dorsomorphin, an established
inhibitor of the AMPK pathway, and 5-Aminoimidazole-4-carboxamide
ribonucleotide (AICAR), an AMPK stimulator. XN increased the
expression of phospho-AMPK and this XN-induced increase in AMPK
activation was diminished in the presence of dorsomorphin. On the
other hand, XN+AICAR demonstrated an additive effect on the
activation of AMPK. Likewise, dorsomorphin reversed XN-induced
inhibition of adipogenesis while XN+AICAR demonstrated an additive
effect on the inhibition of lipid content during adipogenesis. These
results provide evidence for the potential role of AMPK pathway in XNinduced anti-obesity effects in 3T3-L1 adipocytes.
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Role of AMPK in XN – induced Beiging in 3T3-L1 Adipocytes
XN – induced upregulation of UCP-1 is mediated partly
through AMPK signaling pathway

Hypothesis

UCPI expression in mature adipocytes

XN – induced inhibition of
adipogenesis is reversed by AMPK
inhibitor, dorsomorphin

p-AMPK expression in mature adipocytes

Research Goals:
Demonstrate multifaceted anti-obesity effects of XN in 3T3-L1 adipocytes
and to determine the effects of XN on the induction of beiging.
Investigate the possible role of AMPK signaling pathway in XN-induced
beiging.

Role of AMPK in XNinduced anti-obesity
effects: a working
model

*p<0.05
*p <0.05
**p<0.01
***p<0.001 Means that are not denoted with a
****p<0.0001
common letter are different; a, b, c, d
#p<0.05 vs. + control
and e: p < 0.05

Conclusions
• XN drives the beiging of mature 3T3-L1 adipocytes as
demonstrated by increased beige marker expression.
• XN inhibits adipogenesis and stimulates lipolysis.
• XN increases thermogenesis as witnessed by the upregulation of UCP1 and mitochondrial biogenesis, indicative of
further beiging.
• XN activates AMPK signaling pathway as seen with the
upregulation of p-AMPK expression.
• XN-induced upregulation of UCP1 expression is dependent on
AMPK signaling pathway.
• Further studies will be conducted to demonstrate that XNinduced anti-obesity effects are partly mediated through the
activation of AMPK pathway.
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